Advances in Amblyopia: What Have We Learned From PEDIG Trials?
- 1 March 2013
- journal article
- review article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 131 (3) , 540-547
Abstract
Amblyopia is the most common cause of preventable visual loss in children. This article reviews treatment options, durations, and efficacy in randomized multicentered trials conducted by the Pediatric Eye Disease and Investigator Group in the last decade. Parents and patients should be counseled that many forms of treatment are efficacious, allowing the option of choice of best-tolerated treatment method. Compliance is key to successful treatment. The course of treatment is likely at least 6–12 months, with yearly follow-up suggested once amblyopia has been treated to monitor for regression.Keywords
This publication has 37 references indexed in Scilit:
- Effect of Age on Response to Amblyopia Treatment in ChildrenArchives of Ophthalmology (1950), 2011
- Contrast Sensitivity Following Amblyopia Treatment in ChildrenArchives of Ophthalmology (1950), 2009
- Pharmacological Plus Optical Penalization Treatment for AmblyopiaArchives of Ophthalmology (1950), 2009
- Further validation of the Amblyopia Treatment Index parental questionnaireJournal of American Association for Pediatric Ophthalmology and Strabismus, 2008
- Monocular Oral Reading Performance After Amblyopia Treatment in ChildrenAmerican Journal of Ophthalmology, 2008
- A Randomized Trial of Atropine vs Patching for Treatment of Moderate AmblyopiaArchives of Ophthalmology (1950), 2008
- Treatment of Bilateral Refractive Amblyopia in Children Three to Less Than 10 Years of AgeAmerican Journal of Ophthalmology, 2007
- The effect on refractive error of unilateral atropine as compared with patching for the treatment of amblyopiaJournal of American Association for Pediatric Ophthalmology and Strabismus, 2007
- Treatment of Strabismic Amblyopia With Refractive CorrectionAmerican Journal of Ophthalmology, 2007
- Stability of Visual Acuity Improvement Following Discontinuation of Amblyopia Treatment in Children Aged 7 to 12 YearsArchives of Ophthalmology (1950), 2007